Solange Peters, MD, PhD, on SCLC: Expert Perspective on CheckMate 032

2017 ASCO Annual Meeting
Tweet this page

Solange Peters, MD, PhD, of the University of Lausanne, examines the study findings on nivolumab ± ipilimumab in advanced small cell lung cancer, in the first report of a randomized expansion cohort. (Abstract 8503)

Advertisement

Advertisement



Advertisement